Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2000

View Archived Issues

Active Biotech updates agreements for traveler's diarrhea vaccines

Insulin demonstrates antiatherosclerotic properties

Trial reveals utility of acupuncture in treating cocaine dependence

Vanadocenes induce germ cell apoptosis in mouse model of testicular cancer

Roche reports synthesis and antitumor activity of Ro-27-0574

Neurokinin antagonists under development for treatment of respiratory diseases

Sigma-1 and sigma-2 receptor ligands developed

Identification of dual Na+/Ca2+ blocker with antioxidant activity reported by Suntory

Synthetic analogues of 1alpha,25-(OH)2D3 may be useful in cancer chemoprevention

DuPont provides funding for large trial of cardiac imaging in diabetic patients

Phase I trial of novel anticancer treatment under way

Opioid receptor ligands under study at Pfizer

New compounds interacting with opioid receptors useful for IBS, etc.

AT1 antagonists in the treatment of CHF

CRF antagonists from DuPont reportedly useful in depression, etc.

Yeda presents new antiretroviral conjugates

New testosterone derivatives patented by Schering AG

FDA approves Advair Diskus for treatment of asthma

Spironolactone improves survival in CHF, possibly by limiting cardiac fibrosis

FDA accepts Celebrex sNDA for filing

Phase II trial to commence for diabetes vaccine

Individuals with manic depression may have lower heart attack risks

Inex broadens Onco TCS clinical trial program

Chymase inhibition -- a route to cardiovascular drug discovery

Taro to market and distribute Periostat in Israel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...